ALTMAN PETER (President and CEO) purchased 2.1% of their position (7.50K shares) of BIOCARDIA, INC. on the open market
Open‑market purchase worth $7.2K — a small addition. The strongest form of insider conviction signal.
P · 3 purchases
Filed: 7/10/2026ACC: 0001437749-26-023365
DirectorOfficer· President and CEO
Since Aug 2018
+7.50K
Net shares
Net buyer
$7.2K
Total acquired
3
Open market trades
3B · 0S
3
Total transactions
7.50K acquired
Non-Derivative Transactions3
Common Stock
Direct
Shares
+5.50K
Price / share
$0.97
Trade value
$5.33K
% of position
1.5%
7/8/2026
361.99K→367.49K
Common Stock
Direct
Shares
+1K
Price / share
$0.90
Trade value
$900.00
% of position
0.3%
7/9/2026
367.49K→368.49K
Common Stock
Direct
Shares
+1K
Price / share
$0.94
Trade value
$940.00
% of position
0.3%
7/10/2026
368.49K→369.49K
Total
Net shares
+7.50K
Net value
$7.17K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 7/8/2026 | P · Purchase | +5.50K | $0.97 | $5.33K | 1.5% | 361.99K | 367.49K |
| Common Stock Direct | 7/9/2026 | P · Purchase | +1K | $0.90 | $900.00 | 0.3% | 367.49K | 368.49K |
| Common Stock Direct | 7/10/2026 | P · Purchase | +1K | $0.94 | $940.00 | 0.3% | 368.49K | 369.49K |
| Total | +7.50K | $7.17K | ||||||
Derivative Transactions0
No derivative transactions reported